Pacific Biosciences of California, Inc.PACBNASDAQ

Revenue (LTM)

$160M

+3.9% YoY

Net Income (LTM)

$-546M

-76.3% YoY

Free Cash Flow

$-114M

Revenue CAGR (5Y)

+5.2%

Marginsdeclining

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	131	128↓1.7%	201↑56.3%	154↓23.2%	160↑3.9%
Gross Profit	59	49↓16.7%	53↑7.6%	37↓29.4%	51↑35.9%
Operating Income	-210	-307↓46.0%	-334↓8.9%	-474↓41.8%	-558↓17.6%
Net Income	-181	-314↓73.4%	-307↑2.4%	-310↓1.0%	-546↓76.3%
EBITDA	-251	-282↓12.6%	-271↑3.9%	-243↑10.5%	-34↑85.9%
EPS Diluted	-0.89	-1.40↓57.3%	-1.21↑13.6%	-1.07↑11.6%	-1.82↓70.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	461	325↓29.4%	180↓44.7%	55↓69.2%	64↑15.1%
Total Current Assets	1,101	852↓22.6%	742↓12.9%	496↓33.2%	375↓24.3%
Total Assets	2,007	1,767↓12.0%	1,746↓1.2%	1,260↓27.8%	784↓37.8%
Total Current Liabilities	72	263↑267.2%	95↓63.9%	66↓30.2%	54↓17.9%
Total Liabilities	1,216	1,204↓1.0%	1,045↓13.2%	754↓27.8%	779↑3.3%
Total Equity	791	563↓28.8%	701↑24.6%	507↓27.8%	5↓98.9%
Total Debt	955	948↓0.7%	934↓1.5%	672↓28.0%	759↑12.9%
Net Debt	495	623↑26.0%	754↑21.0%	617↓18.2%	696↑12.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-111	-263↓136.7%	-267↓1.3%	-206↑22.7%	-111↑46.0%
Capital Expenditure	-6	-17↓185.4%	-9↑47.8%	-6↑30.0%	-3↑56.1%
Free Cash Flow	-117	-280↓139.2%	-275↑1.7%	-212↑22.9%	-114↑46.3%
Stock-Based Comp	81	79↓2.6%	0	0	0
Net Change in Cash	380	-138↓136.2%	-145↓5.6%	-124↑14.5%	8↑106.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance